Code | 6576D | ||||||||||
MA number | 50/0032/21-S | ||||||||||
Product Form: | tbl 20x40 mg (blis.PVC/PVDC/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Medreg s.r.o., Czechia | ||||||||||
Therapeutic Class: | 50 - DIURETICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/PVDC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 19.02.2021 |
Validity: | 19.02.2026 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
Dokument: | VHS_Furosemid Medreg_SK_H_0238_001_DC_PAR.doc |
Dokument: | VHS_sum_Furosemid Medreg_SK_H_0238_001_DC_summary PAR.doc |
SPC: | SPC_Furosemid Medreg_tbl_05_2024.pdf |
PIL: | PIL_Furosemid Medreg_tbl_05_2024.pdf |
Safety feature | Yes |
Data update: | 23.02.2021 |